CONMED Corp. (CNMD)
51.50
-1.33
(-2.52%)
USD |
NYSE |
Nov 06, 16:00
51.45
-0.05
(-0.10%)
After-Hours: 20:00
CONMED Enterprise Value : 2.306B for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 2.306B |
| November 05, 2026 | 2.346B |
| November 04, 2026 | 2.371B |
| November 03, 2026 | 2.179B |
| November 02, 2026 | 2.160B |
| October 30, 2026 | 2.091B |
| October 29, 2026 | 2.134B |
| October 28, 2026 | 2.135B |
| October 27, 2026 | 2.178B |
| October 26, 2026 | 2.192B |
| October 23, 2026 | 2.239B |
| October 22, 2026 | 2.245B |
| October 21, 2026 | 2.175B |
| October 20, 2026 | 2.189B |
| October 19, 2026 | 2.143B |
| October 16, 2026 | 2.163B |
| October 15, 2026 | 2.176B |
| October 14, 2026 | 2.110B |
| October 13, 2026 | 2.128B |
| October 12, 2026 | 2.123B |
| October 09, 2026 | 2.095B |
| October 08, 2026 | 2.115B |
| October 07, 2026 | 2.089B |
| October 06, 2026 | 2.096B |
| October 05, 2026 | 2.182B |
| Date | Value |
|---|---|
| October 02, 2026 | 2.151B |
| October 01, 2026 | 2.140B |
| September 30, 2026 | 2.149B |
| September 29, 2026 | 2.197B |
| September 28, 2026 | 2.191B |
| September 25, 2026 | 2.158B |
| September 24, 2026 | 2.152B |
| September 23, 2026 | 2.170B |
| September 22, 2026 | 2.181B |
| September 21, 2026 | 2.137B |
| September 18, 2026 | 2.159B |
| September 17, 2026 | 2.180B |
| September 16, 2026 | 2.208B |
| September 15, 2026 | 2.205B |
| September 14, 2026 | 2.188B |
| September 11, 2026 | 2.185B |
| September 10, 2026 | 2.183B |
| September 09, 2026 | 2.204B |
| September 08, 2026 | 2.194B |
| September 04, 2026 | 2.276B |
| September 03, 2026 | 2.279B |
| September 02, 2026 | 2.279B |
| September 01, 2026 | 2.270B |
| August 31, 2026 | 2.292B |
| August 28, 2026 | 2.296B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.017B |
| Becton, Dickinson & Co. | 73.04B |
| Abbott Laboratories | 217.85B |
| AngioDynamics, Inc. | 474.40M |
| Alphatec Holdings, Inc. | 1.679B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 19.80M |
| Revenue (Quarterly) | 335.59M |
| Total Expenses (Quarterly) | 315.79M |
| EPS Diluted (Quarterly) | 0.6571 |
| Gross Profit Margin (Quarterly) | 10.53% |
| Profit Margin (Quarterly) | 5.90% |
| Earnings Yield | 4.69% |
| Operating Earnings Yield | 1.39% |
| Normalized Earnings Yield | 6.018 |